Last $391.75 MXN
Change Today +0.08 / 0.02%
Volume 152.0
PFE* On Other Exchanges
Symbol
Exchange
Xetra
Mexico
SIX Swiss Ex
Stockholm
EN Brussels
Sao Paulo
Bogota
As of 4:08 PM 04/16/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Geno J. Germano

Group President of Global Innovative Pharma Business, Pfizer Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 4 different industries.

52$5,254,047
As of Fiscal Year 2013

Background*

Mr. Geno J. Germano has been Group President of Innovative Products Group at Pfizer Inc. since January 1, 2014. Mr. Germano served as the President and General Manager of Pfizer Specialty Care and Oncology of Pfizer Inc. from December 2010 to December 2013. He served as the President of U S of Wyeth Pharmaceuticals and Women's Health Care at Wyeth LLC since January 2008. He served as Head of specialty businesses of Pfizer Inc. from October 2009 to December 2010. Mr. ...

Read Full Background

Corporate Headquarters*

235 East 42nd Street
New York, New York 10017

United States

Phone: 212-733-2323
Fax: --

Board Members Memberships*

2012-2013
Former Director

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

Salary$926,250
Total Annual Compensation$926,250

Stock Options*

Restricted Stock Awards$1,529,600
All Other Compensation$173,174

Total Compensation*

Total Annual Cash Compensation$2,174,424
Total Short Term Compensation$926,250
Other Long Term Compensation$1,702,774
Total Calculated Compensation$5,254,047
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PFE*:MM $391.75 MXN +0.08

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
2.9M GBP
Kenneth C. Frazier Chairman, Chief Executive Officer and President
Merck & Co. Inc.
$1.5M
Joseph Jimenez MBAChief Executive Officer and Member of Executive Committee
Novartis AG
SFr.3.1M
Christopher A. Viehbacher Chief Executive Officer, Director and Member of Strategy Committee
Sanofi
€3.0M
Severin Schwan Ph.D.Chief Executive Officer and Director
Roche Holding AG
SFr.5.1M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PFIZER INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.